The predictive value of clinical evaluation of response to neoadjuvant chemoradiation therapy for rectal cancer

Tumori

Volumn 91, Issue 5, 2005, Pages 401-405

  Benzoni, Enrico ^a   Cerato, Franz ^a   Cojutti, Alessandro ^a   Milan, Elisa ^a   Pontello, Daniele ^a   Chiaulon, Germana ^b   Sacco, Cosimo ^a   Bresadola, Vittorio ^a   Terrosu, Giovanni ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Chemoradiotherapy; Clinical staging; Predictive value; Rectal cancer

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTITIS; DERMATITIS; DIARRHEA; DISEASE COURSE; ENTERITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEMATURIA; HISTOLOGY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PROCTITIS; RECTOSCOPY; RECTUM CANCER; RECTUM HEMORRHAGE; RECTUM SURGERY; SKIN TOXICITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URETHRITIS;

EID: 28344432343     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160509100504     Document Type: Article

References (24)

1. Vauthey JN, Marsh RW, Zloteki RA, Abdalla EK, Solorzano CC, Bray EJ, Freeman ME, Lauwers GY, Kubilis PS, Mendenhall WM, Copeland III EM: Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann Surg 229: 745-754, 1999.
2. Onaitis MW, Noone RB, Hartwing M, Hurwitz H, Morse M, Jowell P, McGrath K, Lee C, Anscher MS, Clary B, Mantyh C, Pappas TN, Ludwig K, Seigler HF, Tyler DS: Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg, 233: 778-785, 2001.
3. Garcia Aguillar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA: A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum, 46: 298-303, 2003.
4. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg, 194: 131-136, 2002.
5. Benzoni E, Cerato F, Cojutti A, Milan E, Pontello D, Chiaulon G, Sacco C, Bresadola V, Terrosu G: Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish rectal cancer trial. N Engl J Med, 336: 980-987, 1997.
6. Kaminsky-Forrett MC, Conroy T, Luporsi E, Peifert D, Lapeyre M, Boissel P, Guillemin F, Bey P: Prognostic implication of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys, 42: 935-941, 1998.
7. Habr-Gama A, de Souza PM, Ribeiro U Jr, Nadalin W, Gansl R, Sousa AH Jr, Campos FG, Gama-Rodrigues J: Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum, 41: 1087-1096, 1998.
8. Bosset JF, Magnin V, Maingon P, Mantion G, Pellisier EP, Mercier M, Chaillard G, Horiot JC: Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys, 2: 323-327, 2000.
9. Osti MF, Valeriani M, Masoni L, Tombolini V, Maurizi Enrici R: Neoadjuvant chemoradiation for locally advanced carcinoma of the rectum. Tumori, 90: 303-309, 2004.
10. De Paoli A, Innocente R, Buonadonna A, Boz G, Sigon R, Canzonieri V, Frustaci S: Neoadjuvant therapy for rectal cancer: new treatement perspectives. Tumori, 90: 373-378, 2004.
11. Tepper JE, O'Connell M, Niedzwiecki D, Hollis DR, Benson AB, Cummigs B, Gunderson LL, MacDonald JS, Martenson JA, Mayer RJ: Adjuvant therapy in rectal cancer: analysis of stage, sex and local control-final report of intergroup 0114. J Clin Oncol, 20: 1744-1750, 2002.
12. Pahlman L: Neoadjuvant and adjuvant radio and radiochemotherapy of rectal carcinomas. Int J Colorectal Dis, 15: 1-8, 2000.
13. Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, Dorval E, de Calan L, Huten N, le Folch O, Calais G: Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys, 37: 619-627, 1997.
14. Onaitis MW, Noone RB, Fields R, Hurwitz H, Morse M, Jowell P, McGrath K, Lee C, Anscher MS, Clary B, Mantyh C, Pappas TN, Ludwig K, Hilliard F, Seigler HF, Tyler DS: Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol, 8: 801-806, 2001.
15. Williamsson PR, Hellinger MD, Larach SW, Ferrara A: Endorectal ultrasound of T3 and T4 rectal cancers after preoperative chemoradiation. Dis Colon Rectum, 39: 45-49, 1996.
16. Bernini A, Deen KI, Madoff RD, Wong WD: Preoperative adjuvant radiation with chemotherapy for rectal cancer: its impact on stage of disease and the role of endorectal ultrasound. Ann Surg Oncol, 3: 131-135, 1996.
17. Rau B, Hunerbein M, Barth C, Wust P, Haensch W, Riess H, Felix R, Schlag PM: Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg Endosc, 13: 980-984, 1999.
18. Vanagunas A, Lin DE, Stryker SJ: Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy. Am J Gastroenterol, 99: 109-112, 2003.
19. Maier AG, Barton PP, Neuhold NR, Herbst F, Tleky BK, Lechner GR: Peritumoral tissue reaction at transrectal US as a possible cause of overstaging in rectal cancer: histopathologic correlation. Radiology, 203: 785-789, 1997.
20. Kahn H, Alexander A, Raknic J, Nagle D, Fry R: Preoperative staging of irradiate rectal cancers using digital rectal examination, computed tomography, endorectal ultrasound and magnetic resonance does not accurately predict T0, N0 pathology. Dis Colon Rectum, 40: 140-144, 1997.
21. Watanabe M, Sugimura K, Kuroda S, Okizuka H, Ishida T: CT assessment of post irradiation changes in the rectum and perirectal region. Clin Imaging, 19: 182-187, 1995.
22. 3 rectal carcinoma. Ann Surg Oncol, 1: 111-116, 1994.
23. Adam IJ, Mohamdee MO, Martin IG, Scott N, Johnston D, Dixon MF, Quirke P: Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet, 344: 707-711, 1994.
24. Nagtegal ID, Marijenen CAM, Kranenbarg EK, van de Velde CJH, van Krieken JHM: Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol, 26: 350-357, 2002.